In this issue:
- Association between routine skin checks and mortality
- Sun-protective behaviours do not decrease bone mineral density
- Skin cancer risk in organ transplant recipients
- Long-term efficacy and safety of risankizumab in moderate to severe psoriasis
- Long-term efficacy and safety of guselkumab in moderate to severe psoriasis
- Oral prednisone 0.5 mg/kg/day for bullous pemphigoid
- Efficacy of the oral JAK-1 inhibitor SHR0302 for moderate to severe AD
- Changes in skin microbiota after UVB treatment of AD
- Inflammatory skin diseases and chronic kidney disease
- No relationship between AD and depression or anxiety
Please login below to download this issue (PDF)